Ltd. “A.B.-BIOKOM”, like every responsible participant in the pharmaceutical market, cares about the quality of its products and the health of consumers. In this regard, the company has implemented and operates a Pharmaceutical supervision system dealing with the safety of manufactured drugs.

The pharmaceutical supervision system at A.B.-BIOKOM LLC is organized to ensure:

  • monitoring the safety of medicines (1);
  • increasing the company’s responsibility for the quality and safety of drugs (2);
  • timely adoption of adequate measures aimed at improving drug safety (3);
  • timely notification of drug safety (4).

The pharmaceutical supervision activity of the enterprise consists in collecting messages on adverse reactions (ADRs), informing the Regulatory authorities responsible for pharmaceutical supervision about ADRs, training and training personnel on pharmaceutical supervision (FS), maintaining documentation for FS, in accordance with approved procedures.

To fulfill these tasks and in accordance with the requirements of the GVP, the company collects and analyzes information on side effects and drug interactions, and also actively cooperates with practicing doctors of medical institutions and with government supervisory authorities.

A doctor or a consumer can report all problems associated with the use of drugs produced by AB-BIOKOM LLC (unexpected, adverse reaction or lack of the expected therapeutic effect after using the course of the drug) by downloading and filling out an electronic form for reporting an adverse reaction, ineffectiveness of the drug. To do this, you should send a written notice to the legal address of the Company by mail, or inform about it by e-mail (biokom.uz@yandex.ru) or call by phone at (+99890) 350-20-51